Glutamate oxaloacetate transaminase 2 (GOT2) has been repeatedly reported in recent years to be associated with the progression of pancreatic cancer,47, 48 but its role in HCC remains unclear. This evidence concerns the gene GOT2 and hepatocellular carcinoma.